TREATMENT OF CANCER

摘要

The present invention includes the use of at least one agent which induces endoplasmic reticulum (ER) stress together with at least one agent which gives rise to inhibition of protein disulfide isomerase (PDI) or GRP78 function for the preparation of a medicament, more particularly a medicament for the treatment of cancer, and to pharmaceutical compositions comprising an effective amount of at least one agent which induces ER stress together with at least one agent which gives rise to inhibition of PDI or GRP78 function, and which together provide a therapeutic effect.